Table of Contents
- Overview
- Results
- Risks
- Prevention
- Images
Cystic fibrosis screening - neonatal; Immunoreactive trypsinogen; IRT test
What the risks are
Risks associated with the test include:
- Infection (a slight risk any time the skin is broken)
- Anxiety over false positive tests
- False reassurance over false negative tests
Special considerations
The test results do not reveal the severity of the CF. False-positives may occur.
Other tests that look for genetic changes known to cause cystic fibrosis may also be used to screen for CF.
Images
Infant blood sample
Previous Section
Next Section
Neonatal cystic fibrosis screening Prevention
Review Date: 06/01/2011
Reviewed By: Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of
Pediatrics, University of Washington School of Medicine. Also
reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
